Alaunos Therapeutics Statistics
Total Valuation
TCRT has a market cap or net worth of $7.04 million. The enterprise value is $5.65 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TCRT has 2.38 million shares outstanding. The number of shares has increased by 21.68% in one year.
| Current Share Class | 2.38M |
| Shares Outstanding | 2.38M |
| Shares Change (YoY) | +21.68% |
| Shares Change (QoQ) | +6.55% |
| Owned by Insiders (%) | 20.67% |
| Owned by Institutions (%) | 7.19% |
| Float | 1.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,407.93 |
| Forward PS | n/a |
| PB Ratio | 3.23 |
| P/TBV Ratio | 3.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,130.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.45
| Current Ratio | 2.45 |
| Quick Ratio | 1.71 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -198.10% and return on invested capital (ROIC) is -125.27%.
| Return on Equity (ROE) | -198.10% |
| Return on Assets (ROA) | -92.31% |
| Return on Invested Capital (ROIC) | -125.27% |
| Return on Capital Employed (ROCE) | -196.24% |
| Weighted Average Cost of Capital (WACC) | -1.98% |
| Revenue Per Employee | $5,000 |
| Profits Per Employee | -$4.28M |
| Employee Count | 1 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.08% in the last 52 weeks. The beta is -1.13, so TCRT's price volatility has been lower than the market average.
| Beta (5Y) | -1.13 |
| 52-Week Price Change | +3.08% |
| 50-Day Moving Average | 2.98 |
| 200-Day Moving Average | 3.04 |
| Relative Strength Index (RSI) | 49.91 |
| Average Volume (20 Days) | 17,304 |
Short Selling Information
The latest short interest is 14,162, so 0.60% of the outstanding shares have been sold short.
| Short Interest | 14,162 |
| Short Previous Month | 13,529 |
| Short % of Shares Out | 0.60% |
| Short % of Float | 0.75% |
| Short Ratio (days to cover) | 0.89 |
Income Statement
In the last 12 months, TCRT had revenue of $5,000 and -$4.28 million in losses. Loss per share was -$2.20.
| Revenue | 5,000 |
| Gross Profit | -1.36M |
| Operating Income | -4.23M |
| Pretax Income | -4.18M |
| Net Income | -4.28M |
| EBITDA | -4.22M |
| EBIT | -4.23M |
| Loss Per Share | -$2.20 |
Full Income StatementBalance Sheet
The company has $1.39 million in cash and n/a in debt, with a net cash position of $1.39 million or $0.58 per share.
| Cash & Cash Equivalents | 1.39M |
| Total Debt | n/a |
| Net Cash | 1.39M |
| Net Cash Per Share | $0.58 |
| Equity (Book Value) | 2.15M |
| Book Value Per Share | 0.92 |
| Working Capital | 1.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.87 million and capital expenditures -$98,000, giving a free cash flow of -$2.97 million.
| Operating Cash Flow | -2.87M |
| Capital Expenditures | -98,000 |
| Depreciation & Amortization | 7,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -2.97M |
| FCF Per Share | -$1.25 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -84,500.00% |
| Pretax Margin | -83,520.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TCRT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.68% |
| Shareholder Yield | -21.68% |
| Earnings Yield | -60.83% |
| FCF Yield | -42.15% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 18, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 18, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
TCRT has an Altman Z-Score of -436.79 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -436.79 |
| Piotroski F-Score | 1 |
